• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX

PRESCIENT THERAPEUTICS LIMITED - Charts / Financials

2.44% ! 4.2¢
Market Cap $44.16M  !

Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing... Prescient Therapeutics (ASX: PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cell therapies.More

refresh Created with Sketch. REFRESH
Last update - 15.31pm 03/09/2025 (20 minute delay) ?
Day
Open 4.1¢   Day High 4.2¢   Day Low 4.1¢
Daily Volume 273878
Bids   Sellers
Number Price Volume   Number Price Volume
7 4.1¢ 469829   2 4.2¢ 57366

Directors & Senior Management

Mr. James Mcdonnell Chief Executive Officer
Ms. Melanie Jaye Leydin Chief Financial Officer, Company Secretary
Dr. Marissa Lim Chief Medical Officer
Dr. James A. Campbell Non-Executive Chairman of the Board
Dr. Allen James Ebens Non-Executive Director
Ms. Melanie Farris Non-Executive Director
Dr. Ellen Gwen Feigal Non-Executive Independent Director
Dr. Gavin James Shepherd Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.2¢
Change
0.001(2.44%)
Mkt cap ! $44.16M
Open High Low Value Volume
4.1¢ 4.2¢ 4.1¢ $11.24K 273.8K

Buyers (Bids)

No. Vol. Price($)
7 469829 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 57366 2
View Market Depth
Last trade - 15.07pm 03/09/2025 (20 minute delay) ?
Last
4.1¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
4.1¢ 4.2¢ 4.1¢ 160314
Last updated 15.31pm 03/09/2025 ?
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.